See every side of every news story
Published loading...Updated

Luxembourg’s Exobiosphere raises €2M to accelerate drug discovery in space; here’s why and how - Silicon Canals

Summary by Silicon Canals
Luxembourg-based Exobiosphere, the world’s first contract research organisation dedicated to drug discovery in space, has raised €2M in a seed funding round. The round was led by Expansion Ventures, with participation from Expon Capital, Boryung, and Space Data Inc. Expansion Ventures is a €200M pan-European venture capital fund backing category-defining founders in aerospace and defence. “Exobiosphere brings a fresh, high-impact perspective to …
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Labiotech.eu broke the news in on Friday, April 4, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.